Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843843 · ClinicalTrials.gov registry record · NA
Sleep Length and Circadian Regulation in Humans
A NA study of Sleep Disorders, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT00843843: Completed NA study of Sleep Disorders, sponsored by Rush University Medical Center.
NCT00843843 is a NA study of Sleep Disorders that has completed, run by Rush University Medical Center. The registered enrollment target is 16 participants, below the 328-participant average among 19 other Sleep Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00843843, a NA study of Sleep Disorders, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will examine why sleep restriction reduces the body clock's response to bright light. The results will enable the optimization of the bright light treatment of people who suffer from circadian rhythm sleep disorders, which include shift work sleep disorder, jet lag, delayed sleep phase syndrome and winter depression, thereby improving public health and safety, well-being, mood, mental function, and quality of life.
Primary Outcome
Gold standard marker of circadian timing
Conditions Studied
Interventions
- DEVICE Bright light box
Study Locations (1)
Illinois
- Biological Rhythms Research Laboratory, RUMC - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-03 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT00843843 record still lists
NCT00843843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 328-participant average among 19 other Sleep Disorders trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Sleep Disorders appearing as the primary indexed condition, and to 1 intervention - of which Bright light box is the first listed.
NCT00843843 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00843843 about?
NCT00843843 is a clinical study titled "Sleep Length and Circadian Regulation in Humans". This research will examine why sleep restriction reduces the body clock's response to bright light. The results will enable the optimization of the bright light treatment of people who suffer from circadian rhythm sleep disorders, which include shift work sleep disorder, jet lag, delayed sleep phase...
What is the current status of trial NCT00843843?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-03. Estimated completion is 2014-02.
What conditions does trial NCT00843843 study?
This clinical trial studies the following conditions: Sleep Disorders.
What interventions are being tested in trial NCT00843843?
The interventions under investigation include: Bright light box (DEVICE).
Who is sponsoring clinical trial NCT00843843?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00843843 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00843843's enrollment target sits among peer trials
16 19th of 19 higher than 1 of 19 other Sleep Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
ACTIVE NOT RECRUITING · NA
-
Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
ACTIVE NOT RECRUITING · NA
-
Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease
COMPLETED · NA
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
COMPLETED · NA
-
Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study
COMPLETED · NA
-
Zolpidem CR and Hospitalized Patients With Dementia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia